Status:
RECRUITING
Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Solid-organ transplant patients are at increased risk of infectious diseases. Among this population, infectious diseases may be life-threatening or lead to graft rejection. Their prevention is an impo...
Detailed Description
The main objective of this study is to impove vaccine coverage before kidney transplantation. Enrollment was based on the waiting list for a kidney transplant. Patients newly listed are invited to pa...
Eligibility Criteria
Inclusion
- Patient over 18
- On the waiting list for kidney transplantation at Clermont-Ferrand
- Free and informed consent
- Affiliation to a social security system
Exclusion
- Patient under 18
- Protected adults (individuals under guardianship by court order
- Pregnant and nursing women
- Prior graft (solid organs or hematopoietic stem cells)
- Absence of consent
Key Trial Info
Start Date :
September 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04791098
Start Date
September 16 2020
End Date
April 1 2026
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000